Group co-chairs Peter O'Dwyer and Mitch Schnall commend the selection of Monica Bertagnolli as the next NCI director

The Cancer Letter

Monica M. Bertagnolli, MD, a professor of surgery at Harvard Medical School and group chair of the Alliance for Clinical Trials in Oncology stands poised to become the first woman and the first chair of a clinical trials cooperative group to be named director of the National Cancer Institute. ECOG-ACRIN Group Co-Chairs Peter J. O'Dwyer, MD, and Mitchell D. Schnall, MD, PhD, share their excitement over the appointment in this special report.